1
|
Shah S, Morris H, Thiagarajah S, Gordon A, Sharma S, Haslam P, Garcia J, Ali F. Handling 'carbon footprint' in orthopaedics. Ann R Coll Surg Engl 2024. [PMID: 38563077 DOI: 10.1308/rcsann.2023.0052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2024] Open
Abstract
INTRODUCTION The National Health Service contributes 4%-5% of England and Wales' greenhouse gases and a quarter of all public sector waste. Between 20% and 33% of healthcare waste originates from a hospital's operating room, and up to 90% of waste is sent for costly and unneeded hazardous waste processing. The goal of this study was to quantify the amount and type of waste produced during a selection of common trauma and elective orthopaedic operations, and to calculate the carbon footprint of processing the waste. METHODS Waste generated for both elective and trauma procedures was separated primarily into clean and contaminated, paper or plastic, and then weighed. The annual carbon footprint for each operation at each site was subsequently calculated. RESULTS Elective procedures can generate up to 16.5kg of plastic waste per procedure. Practices such as double-draping the patient contribute to increasing the quantity of waste. Over the procedures analysed, the mean total plastic waste at the hospital sites varied from 6 to 12kg. One hospital site undertook a pilot of switching disposable gowns for reusable ones with a subsequent reduction of 66% in the carbon footprint and a cost saving of £13,483.89. CONCLUSIONS This study sheds new light on the environmental impact of waste produced during trauma and elective orthopaedic procedures. Mitigating the environmental impact of the operating room requires a collective drive for a culture change to sustainability and social responsibility. Each clinician can have an impact upon the carbon footprint of their operating theatre.
Collapse
Affiliation(s)
- S Shah
- Sheffield Teaching Hospitals NHS Foundation Trust, UK
- Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, UK
| | - H Morris
- East Midlands North Training Rotation, UK
| | - S Thiagarajah
- Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, UK
| | - A Gordon
- Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - S Sharma
- Barnsley Hospital NHS Foundation Trust, UK
| | - P Haslam
- Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, UK
- Sheffield Children's NHS Foundation Trust, UK
| | - J Garcia
- Chesterfield Royal Hospital NHS Foundation Trust, UK
| | - F Ali
- Sheffield Children's NHS Foundation Trust, UK
- Chesterfield Royal Hospital NHS Foundation Trust, UK
| |
Collapse
|
2
|
Shah S, Morris H, Nicolaou N, MacInnes S, Haslam P, Shahane S, Ali F, Garcia J. The carbon footprint of arthroscopic procedures. Ann R Coll Surg Engl 2024; 106:256-261. [PMID: 37381779 PMCID: PMC10906500 DOI: 10.1308/rcsann.2023.0036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/14/2023] [Indexed: 06/30/2023] Open
Abstract
INTRODUCTION The healthcare sector contributes the equivalent of 4.4% of global net emissions to the climate carbon footprint; between 20% and 70% of healthcare waste originates from a hospital's operating theatre and up to 90% of waste is sent for costly and unneeded hazardous waste processing. This study aimed to quantify the amount and type of waste produced during an arthroscopic anterior cruciate ligament reconstruction (ACLR) and an arthroscopic rotator cuff repair (RCR), calculate the carbon footprint and assess the cost of the waste disposal. METHODS The amount of waste generated from ACLR and RCR procedures was calculated across a range of hospital sites. The waste was separated primarily into clean and contaminated, paper or plastic. Both carbon footprint and cost of disposal across the hospital sites was subsequently calculated. RESULTS RCR generated 3.3-15.5kg of plastic waste and 0.9-2.3kg of paper waste. ACLR generated 2.4-9.6kg of plastic waste and 1.1-1.6kg of paper waste. The cost to process waste varies widely between hospital sites, waste disposal contractors and method of waste disposal. The annual burden of the included hospital sites for the arthroscopic procedures undertaken was 6.2 tonnes of carbon dioxide. CONCLUSIONS The data collected demonstrated a significant variability in waste production and cost for waste disposal between hospital sites. At a national level, consideration should be given to the procurement of appropriate products such that waste can be efficiently recycled or disposed of by environmentally sustainable methods.
Collapse
Affiliation(s)
| | - H Morris
- East Midlands North Training Rotation, UK
| | - N Nicolaou
- Sheffield Children’s NHS Foundation Trust, UK
| | - S MacInnes
- Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, UK
| | | | - S Shahane
- Chesterfield Royal Hospital NHS Foundation Trust, UK
| | - F Ali
- Chesterfield Royal Hospital NHS Foundation Trust, UK
| | - J Garcia
- Chesterfield Royal Hospital NHS Foundation Trust, UK
| |
Collapse
|
3
|
Baydoun A, Sun Y, Jia AY, Zaorsky NG, Shoag JE, Vince RA, Ponsky L, Barata P, Garcia J, Berlin A, Ramotar M, Finelli A, Wallis CJD, van der Kwast T, Spratt DE. Post-Prostatectomy Risk Stratification of Biochemical Recurrence Using Transfer Learning-Based Multi-Modal Artificial Intelligence. Int J Radiat Oncol Biol Phys 2023; 117:S83-S84. [PMID: 37784586 DOI: 10.1016/j.ijrobp.2023.06.404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) For patients undergoing radical prostatectomy for prostate cancer (PCa), accurate risk stratification is essential to guide post-prostatectomy therapeutic decision making. Recently, there has been success in the use of multi-modal artificial intelligence models for men after prostate biopsy to aid in risk stratification. Herein, we trained and tested a TRansfer learning-based multi-modal Artificial InteLligence model (TRAIL) for biochemical recurrence (BCR) risk stratification following radical prostatectomy. MATERIALS/METHODS Patients contained within a prospective PCa registry at a single institution were utilized. Digital pathology slides from the diagnostic biopsies prior to radical prostatectomy for patients with clinically localized PCa were scanned at 20x resolution. Features were extracted for the TRAIL model from pathology slides via two transfer learning steps: (1) InceptionResNetv2 that first determines a heatmap of tumor areas, and (2) A ResNet18 that extracts representative features from the high tumor probability areas. Least Absolute Shrinkage and Selection Operator (LASSO) was used for feature selection from the pathology-extracted features. Finally, TRAIL combines the clinical and pathology-extracted features via a classification ensemble model based on weak tree learners to predict 2- and 5-year BCR defined as two consecutive serum PSA levels ≥0.2 ng/mL. TRAIL training was performed on 250 patients and was then locked and applied to the test set of 125 patients. Accuracy and the area under the curve (AUC) were calculated. Comparison to CAPRA-S and to clinical-only features were assessed. RESULTS A total of 818 digital whole pathology biopsy slides from 375 patients treated with subsequent radical prostatectomy were included. Surgical margins were positive in 29% of the patients, and 41% had extra-prostatic extension. The median follow-up was 48 months (Range: 1-132 months). The rates of 2-and 5-year BCR were 11% and 18% respectively. A total of 19 digital pathology-driven features were included in TRAIL. Clinical factors included age, ISUPG, Gleason score, PSA, pathological T and N stages, surgical margin involvement, and the presence of extra-prostatic extension. On the testing set, TRAIL achieved a 2-year BCR AUC of 0.76 and accuracy of 0.87, and was superior to CAPRA-S (AUC = 0.57) and clinical-only features (AUC 0.50, accuracy 0.14). For 5-year BCR, TRAIL achieved an AUC of 0.69 and accuracy of 0.78, and performed better than CAPRA-S (AUC = 0.58), and clinical only features (AUC = 0.50, accuracy = 0.23). CONCLUSION Through a combination of deep and ensemble learning, TRAIL incorporates clinical and histopathology features, enabling an improved BCR risk stratification post-prostatectomy when compared to the currently used clinicopathologic models. Future work with larger datasets with metastatic events is warranted to further optimize the model for clinical use.
Collapse
Affiliation(s)
- A Baydoun
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - Y Sun
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - A Y Jia
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - N G Zaorsky
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - J E Shoag
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - R A Vince
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - L Ponsky
- Urology, University Hospitals Cleveland Medical Center, Cleveland, OH
| | - P Barata
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - J Garcia
- University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
| | - A Berlin
- Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
| | - M Ramotar
- Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada
| | - A Finelli
- Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
| | - C J D Wallis
- Mount Sinai Hospital, UHN, University of Toronto, Toronto, ON, Canada
| | | | - D E Spratt
- Department of Radiation Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH
| |
Collapse
|
4
|
Kiptily VG, Dumont R, Fitzgerald M, Keeling D, Sharapov SE, Poradzinski M, Štancar Ž, Bonofiglo PJ, Delabie E, Ghani Z, Goloborodko V, Menmuir S, Kowalska-Strzeciwilk E, Podestà M, Sun H, Taylor DM, Bernardo J, Carvalho IS, Douai D, Garcia J, Lennholm M, Maggi CF, Mailloux J, Rimini F, Siren P. Evidence of Electron Heating by Alpha Particles in JET Deuterium-Tritium Plasmas. Phys Rev Lett 2023; 131:075101. [PMID: 37656860 DOI: 10.1103/physrevlett.131.075101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Revised: 05/03/2023] [Accepted: 06/16/2023] [Indexed: 09/03/2023]
Abstract
The fusion-born alpha particle heating in magnetically confined fusion machines is a high priority subject for studies. The self-heating of thermonuclear fusion plasma by alpha particles was observed in recent deuterium-tritium (D-T) experiments on the joint European torus. This observation was possible by conducting so-called "afterglow" experiments where transient high fusion yield was achieved with neutral beam injection as the only external heating source, and then termination of the heating at peak performance. This allowed the first direct evidence for electron heating of plasmas by fusion-born alphas to be obtained. Interpretive transport modeling of the relevant D-T and reference deuterium discharges is consistent with the alpha particle heating observation.
Collapse
Affiliation(s)
- V G Kiptily
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - R Dumont
- CEA - IRFM, 13115 Saint-Paul-lez-Durance, France
| | - M Fitzgerald
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - D Keeling
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - S E Sharapov
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - M Poradzinski
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - Ž Štancar
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
- Joźef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia
| | - P J Bonofiglo
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - E Delabie
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - Z Ghani
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - V Goloborodko
- Kyiv Institute for Nuclear Research, 03680 Kyiv, Ukraine
| | - S Menmuir
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | | | - M Podestà
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - H Sun
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - D M Taylor
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - J Bernardo
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
- Instituto de Plasmas e Fusão Nuclear, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal
| | - I S Carvalho
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
- Instituto de Plasmas e Fusão Nuclear, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal
| | - D Douai
- CEA - IRFM, 13115 Saint-Paul-lez-Durance, France
| | - J Garcia
- CEA - IRFM, 13115 Saint-Paul-lez-Durance, France
| | - M Lennholm
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - C F Maggi
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - J Mailloux
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - F Rimini
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| | - P Siren
- United Kingdom Atomic Energy Authority, Culham Science Centre, Abingdon, Oxon, OX14 3DB, United Kingdom
| |
Collapse
|
5
|
Gambelli CN, Bredin J, Doix ACM, Garcia J, Tanant V, Fournier-Mehouas M, Desnuelle C, Sacconi S, Colson SS. The effect of tibialis anterior weakness on foot drop and toe clearance in patients with facioscapulohumeral dystrophy. Clin Biomech (Bristol, Avon) 2023; 102:105899. [PMID: 36738507 DOI: 10.1016/j.clinbiomech.2023.105899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Revised: 01/25/2023] [Accepted: 01/25/2023] [Indexed: 02/01/2023]
Abstract
BACKGROUND Facioscapulohumeral dystrophy is a genetic disease characterized by progressive muscle weakness leading to a complex combination of postural instability, foot drop during swing and compensatory strategies during gait that have been related to an increased risk of falling. The aim is to assess the effect of tibialis anterior muscle weakness on foot drop and minimum toe clearance of patients with facioscapulohumeral dystrophy during gait. METHODS Eight patients allocated to a subgroup depending on the severity of tibialis anterior muscle weakness, assessed by manual muscle testing (i.e., severe and mild weakness), and eight matched control participants underwent gait analysis at self-selected walking speeds. FINDINGS Walking speed, for all facioscapulohumeral dystrophy patients, and step length, for patients with severe weakness only, were significantly decreased compared to control participants. Minimum toe clearance was similar across all groups, but its variability was increased only for patients with severe weakness. A greater foot drop was systematically observed for patients with severe weakness during swing and only in late swing for patients with mild weakness. Individual strategies to compensate for foot drop remain unclear and may depend on other muscle impairment variability. INTERPRETATION Although all patients were able to control the average height of their foot trajectory during swing, patients with severe tibialis anterior muscle weakness exhibited increased foot drop and minimum toe clearance variability. Manual muscle testing is a simple, cheap and effective method to assess tibialis anterior muscle weakness and seems promising to identify facioscapulohumeral dystrophy patients with an increased risk of tripping.
Collapse
Affiliation(s)
- C N Gambelli
- Physical Activity, Sport and Recreation Research Focus Area (PhASRec), Potchefstroom Campus, North-West University (NWU), Potchefstroom, South Africa; Université Côte d'Azur, LAMHESS, France; Laboratory of Physiology and Biomechanics of Locomotion, Institute of Neuroscience (IoNS), Université catholique de Louvain (UCL), Louvain-la-Neuve, Belgium.
| | - J Bredin
- Université Côte d'Azur, LAMHESS, France; Centre de Santé Institut Rossetti-PEP06, Nice, France
| | | | - J Garcia
- Université Côte d'Azur, CHU, France
| | - V Tanant
- Université Côte d'Azur, CHU, France
| | - M Fournier-Mehouas
- Université Côte d'Azur, LAMHESS, France; Université Côte d'Azur, CHU, France
| | - C Desnuelle
- Université Côte d'Azur, CNRS, Inserm, iBV, France
| | - S Sacconi
- Université Côte d'Azur, CHU, France; Université Côte d'Azur, CHU, CNRS, Inserm, IRCAN, France
| | | |
Collapse
|
6
|
Giruzzi G, Fontana M, Orsitto F, de la Luna E, Dumont R, Figini L, Maslov M, Mazzi S, Schmuck S, Senni L, Sozzi C, Challis C, Frigione D, Garcia J, Garzotti L, Hobirk J, Kappatou A, Keeling D, Lerche E, Maggi C, Mailloux J, Rimini F, Van Eester D. A model of non-Maxwellian electron distribution function for the analysis of ECE data in JET discharges. EPJ Web Conf 2023. [DOI: 10.1051/epjconf/202327703005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
Recent experiments performed in JET at high level of plasma heating, in preparation of, and during the DT campaign have shown significant discrepancies between electron temperature measurements by Thomson Scattering (TS) and Electron Cyclotron Emission (ECE). In order to perform a systematic analysis of this phenomenon, a simple model of bipolar distortion of the electron distribution function has been developed, allowing analytic calculation of the EC emission and absorption coefficients. Extensive comparisons of the modelled ECE spectra (at both the 2nd and the 3rd harmonic extraordinary mode) with experimental measurements display good agreement when bulk electron distribution distortions around 1-2 times the electron thermal velocity are used and prove useful for a first level of analysis of this effect.
Collapse
|
7
|
Treanore ED, Ramos-Medero AV, Garcia J, Amsalem E. The Effect of Pollen Diet Composition and Quantity on Diapause Survival and Performance in an Annual Pollinator ( Bombus Impatiens). Integr Org Biol 2023; 5:obad014. [PMID: 37139245 PMCID: PMC10150274 DOI: 10.1093/iob/obad014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 03/31/2023] [Accepted: 04/13/2023] [Indexed: 05/05/2023] Open
Abstract
Most pollination services are provided by annual bees that go through a winter diapause, during which they are exposed to extreme temperatures, pathogens, and starvation. The ability of bees to successfully face these stressors during diapause and subsequently initiate a nest depends on their overall nutritional state and an adequate preparatory diet. Here, we used queens of the common eastern bumble bee, Bombus impatiens, to examine how pollen diets varying in their protein to lipid ratio and total nutrient amounts affected queen performance during and after diapause. We compared diapause survival and reproductive performance post-diapause across different diets and found that queen survival was highest when pollen had a nutritional ratio of approximately 5:1 (protein to lipid). This diet is significantly enriched in proteins compared to the pollen fed to bumble bees in the lab (1:1) or commonly available in agricultural landscapes. Altering the quantity of macronutrients within this ratio did not improve survival or performance. Our results emphasize the importance of adequate nutrition for diapause performance in bees with annual life cycles and the importance of providing annual bees with floral provisioning based on their individual nutritional targets.
Collapse
Affiliation(s)
| | - A V Ramos-Medero
- Department of Entomology, Center for Chemical Ecology, Center for Pollinator Research, Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA
| | - J Garcia
- Department of Entomology, Center for Chemical Ecology, Center for Pollinator Research, Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA
| | - E Amsalem
- Department of Entomology, Center for Chemical Ecology, Center for Pollinator Research, Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA
| |
Collapse
|
8
|
Fontana M, Giruzzi G, Orsitto FP, de la Luna E, Dumont R, Figini L, Kos D, Maslov M, Schmuck S, Sozzi C, Challis CD, Frigione D, Garcia J, Garzotti L, Hobirk J, Kappatou A, Keeling D, Lerche E, Maggi C, Mailloux J, Rimini F, Van Eester D. Investigation of Te measurements discrepancies between ECE and Thomson diagnostics in high-performance plasmas in JET. EPJ Web Conf 2023. [DOI: 10.1051/epjconf/202327703006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
For high-temperature JET and TFTR discharges, electron cyclotron emission (ECE) measurements of central electron temperature were systematically found to be up to 20% higher than those taken with Thomson scattering. In recent high-performance JET discharges, central Te measurements, performed with LIDAR Thomson scattering and the X-mode ECE interferometer, have been studied in a large database, including deuterium (DD), and deuterium-tritium plasmas (DT). Discrepancies between Te measurements have been observed outside of the experimental uncertainties. ECE measurements, at high Te, have been found to be higher or lower than those of LIDAR, depending on the specific plasma scenario. In addition, discrepancies between the peaks of the second and third harmonic ranges of the ECE spectrum have been interpreted as evidence for the presence of non-Maxwellian features in the electron distribution function. These comparisons seem to suggest that such features can be found in most of the high-performance scenarios selected in this JET database.
Collapse
|
9
|
Baydoun A, Sun Y, Sandler H, Bolla M, Nabid A, Denham J, Jia A, Zaorsky N, Garcia J, Brown J, Jackson W, Dess R, Efstathiou J, Feng F, Maingon P, Steigler A, Souhami L, Berlin A, Kishan A, Spratt D. Efficacy of Bicalutamide Monotherapy in Prostate Cancer: A Network Meta-Analysis of 10 Randomized Trials. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
10
|
Tardocchi M, Rebai M, Rigamonti D, Tinguely RA, Caruggi F, Croci G, Dal Molin A, Ghani Z, Giacomelli L, Girolami M, Grosso G, Kushoro M, Marcer G, Mastellone M, Muraro A, Nocente M, Perelli Cippo E, Petruzzo M, Putignano O, Scionti J, Serpente V, Trucchi DM, Mackie S, Saltos AA, De Marchi E, Parisi M, Trotta A, de la Luna E, Garcia J, Kazakov Y, Maslov M, Stancar Z, Gorini G. A high-resolution neutron spectroscopic camera for the SPARC tokamak based on the Jet European Torus deuterium-tritium experience. Rev Sci Instrum 2022; 93:113512. [PMID: 36461481 DOI: 10.1063/5.0101779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/03/2022] [Accepted: 09/19/2022] [Indexed: 06/17/2023]
Abstract
Dedicated nuclear diagnostics have been designed, developed, and built within EUROFUSION enhancement programs in the last ten years for installation at the Joint European Torus and capable of operation in high power Deuterium-Tritium (DT) plasmas. The recent DT Experiment campaign, called DTE2, has been successfully carried out in the second half of 2021 and provides a unique opportunity to evaluate the performance of the new nuclear diagnostics and for an understanding of their behavior in the record high 14 MeV neutron yields (up to 4.7 × 1018 n/s) and total number of neutrons (up to 2 × 1019 n) achieved on a tokamak. In this work, we will focus on the 14 MeV high resolution neutron spectrometers based on artificial diamonds which, for the first time, have extensively been used to measure 14 MeV DT neutron spectra with unprecedented energy resolution (Full Width at Half Maximum of ≈1% at 14 MeV). The work will describe their long-term stability and operation over the DTE2 campaign as well as their performance as neutron spectrometers in terms of achieved energy resolution and high rate capability. This important experience will be used to outline the concept of a spectroscopic neutron camera for the SPARC tokamak. The proposed neutron camera will be the first one to feature the dual capability to measure (i) the 2.5 and 14 MeV neutron emissivity profile via the conventional neutron detectors based on liquid or plastics scintillators and (ii) the 14 MeV neutron spectral emission via the use of high-resolution diamond-based spectrometers. The new opportunities opened by the spectroscopic neutron camera to measure plasma parameters will be discussed.
Collapse
Affiliation(s)
- M Tardocchi
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - M Rebai
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - D Rigamonti
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - R A Tinguely
- Plasma Science and Fusion Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - F Caruggi
- Università degli Studi di Milano-Bicocca, Milano, Italy
| | - G Croci
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - A Dal Molin
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - Z Ghani
- Culham Centre for Fusion Energy, Abingdon, United Kingdom
| | - L Giacomelli
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - M Girolami
- Istituto di Struttura della Materia, CNR, Montelibretti, Roma, Italy
| | - G Grosso
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - M Kushoro
- Università degli Studi di Milano-Bicocca, Milano, Italy
| | - G Marcer
- Università degli Studi di Milano-Bicocca, Milano, Italy
| | - M Mastellone
- Istituto di Struttura della Materia, CNR, Montelibretti, Roma, Italy
| | - A Muraro
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - M Nocente
- Università degli Studi di Milano-Bicocca, Milano, Italy
| | - E Perelli Cippo
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - M Petruzzo
- Università degli Studi di Milano-Bicocca, Milano, Italy
| | - O Putignano
- Università degli Studi di Milano-Bicocca, Milano, Italy
| | - J Scionti
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| | - V Serpente
- Istituto di Struttura della Materia, CNR, Montelibretti, Roma, Italy
| | - D M Trucchi
- Istituto di Struttura della Materia, CNR, Montelibretti, Roma, Italy
| | - S Mackie
- Plasma Science and Fusion Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A A Saltos
- Commonwealth Fusion Systems, Cambridge, Massachusetts 02139, USA
| | - E De Marchi
- Magnetic Fusion Energy DE - R&D/MAFE, ENI, Venezia, Italy
| | - M Parisi
- Magnetic Fusion Energy DE - R&D/MAFE, ENI, Venezia, Italy
| | - A Trotta
- Magnetic Fusion Energy DE - R&D/MAFE, ENI, Venezia, Italy
| | - E de la Luna
- Laboratorio Nacional de Fusion CIEMAT, Madrid, Spin
| | - J Garcia
- CEA, IRFM, Saint Paul lez Durance, France
| | - Y Kazakov
- Laboratory for Plasma Physics, LPP ERM/KMS, Brussels, Belgium
| | - M Maslov
- Culham Centre for Fusion Energy, Abingdon, United Kingdom
| | - Z Stancar
- Culham Centre for Fusion Energy, Abingdon, United Kingdom
| | - G Gorini
- Istituto per la Scienza e Tecnologia dei Plasmi, CNR, Milano, Italy
| |
Collapse
|
11
|
Hernandez S, Rodriguez Carrillo J, Caminoa A, Benito A, Martinez R, Alonso M, Clave S, Arriola E, Esteban-Rodriguez I, De Castro J, Sansano I, Felip E, Abdulkader I, Garcia J, Rojo F, Domine M, Teixido C, Reguart N, Compañ D, Insa A, Mancheño N, Palanca S, Juan O, Baixeras N, Nadal E, Cebollero M, Calles A, Martin P, Salas C, Provencio M, Aranda I, Massuti B, Lopez-Vilaro L, Majem M, Garrido P, Paz-Ares L, Lopez-Rios F, Conde E. P2.07-02 RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
12
|
Bonofiglo PJ, Kiptily V, Goloborodko V, Štancar Ž, Podestà M, Cecil FE, Challis CD, Hobirk J, Kappatou A, Lerche E, Carvalho IS, Garcia J, Mailloux J, Maggi CF, Meigs AG. Lost alpha Faraday cup foil noise characterization during Joint European Torus plasma post-processing analysis. Rev Sci Instrum 2022; 93:093527. [PMID: 36182470 DOI: 10.1063/5.0099314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Accepted: 08/18/2022] [Indexed: 06/16/2023]
Abstract
Capacitive plasma pickup is a well-known and difficult problem for plasma-facing edge diagnostics. This problem must be addressed to ensure an accurate and robust interpretation of the real signal measurements vs noise. The Faraday cup fast ion loss detector array of the Joint European Torus (JET) is particularly prone to this issue and can be used as a testbed to prototype solutions. The issue of separation and distinction between warranted fast ion signal and electromagnetic plasma noise has traditionally been solved with hardware modifications, but a more versatile post-processing approach is of great interest. This work presents post-processing techniques to characterize the signal noise. While hardware changes and advancements may be limited, the combination with post-processing procedures allows for more rapid and robust analysis of measurements. The characterization of plasma pickup noise is examined for alpha losses in a discharge from JET's tritium campaign. In addition to highlighting the post-processing methodology, the spatial sensitivity of the detector array is also examined, which presents significant advantages for the physical interpretation of fast ion losses.
Collapse
Affiliation(s)
- P J Bonofiglo
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - V Kiptily
- UKAEA, CCFE, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - V Goloborodko
- Kyiv Institute for Nuclear Research, Prospekt Nauky 47, Kyiv 03680, Ukraine
| | - Ž Štancar
- UKAEA, CCFE, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - M Podestà
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - F E Cecil
- Colorado School of Mines, Golden, Colorado 80401, USA
| | - C D Challis
- UKAEA, CCFE, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - J Hobirk
- Max-Planck-Institut für Plasmaphysik, D-85748 Garching, Germany
| | - A Kappatou
- Max-Planck-Institut für Plasmaphysik, D-85748 Garching, Germany
| | - E Lerche
- UKAEA, CCFE, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - I S Carvalho
- Instituto de Plasmas e Fusão Nuclear, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisbon, Portugal
| | - J Garcia
- CEA-IRFM, F-13108 Saint Paul Lez Durance, France
| | - J Mailloux
- UKAEA, CCFE, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - C F Maggi
- UKAEA, CCFE, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| | - A G Meigs
- UKAEA, CCFE, Culham Science Centre, Abingdon, Oxon OX14 3DB, United Kingdom
| |
Collapse
|
13
|
Marcer G, Khilkevitch E, Shevelev A, Croci G, Dal Molin A, Gorini G, Grosso G, Muraro A, Nocente M, Perelli Cippo E, Putignano O, Rebai M, Rigamonti D, de la Luna E, Garcia J, Kazakov Y, Kiptily V, Maslov M, Nave MFF, Ongena J, Tardocchi M. A new dedicated signal processing system for gamma-ray spectrometers in high power deuterium-tritium plasma scenarios in tokamaks. Rev Sci Instrum 2022; 93:093525. [PMID: 36182521 DOI: 10.1063/5.0101611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Accepted: 08/19/2022] [Indexed: 06/16/2023]
Abstract
The most performant deuterium-tritium (DT) plasma discharges realized by the Joint European Torus (JET) tokamak in the recent DT campaign have produced neutron yields on the order of 1018 n/s. At such high neutron yields, gamma-ray spectroscopy measurements with scintillators are challenging as events from the neutron-induced background often dominate over the signal, leading to a significant fraction of pileup events and instability of the photodetector gain along with the consequent degradation of the reconstructed spectrum. Here, we describe the solutions adopted for the tangential lanthanum bromide spectrometer installed at JET. A data acquisition system with free streaming mode digitization capabilities for the entire duration of the discharge has been used to solve dead-time related issues and a data reconstruction code with pileup recovery and photodetector gain drift restoration has been implemented for off-line analysis of the data. This work focuses on the acquired data storage and parsing, with a detailed explanation of the pileup recovery and gain drift restoration algorithms.
Collapse
Affiliation(s)
- G Marcer
- Department of Physics, University of Milan-Bicocca, Milan, Italy
| | | | - A Shevelev
- Ioffe Institute, St. Petersburg, Russian Federation
| | - G Croci
- Department of Physics, University of Milan-Bicocca, Milan, Italy
| | - A Dal Molin
- Institute for Plasma Science and Technology, CNR, Milan, Italy
| | - G Gorini
- Department of Physics, University of Milan-Bicocca, Milan, Italy
| | - G Grosso
- Institute for Plasma Science and Technology, CNR, Milan, Italy
| | - A Muraro
- Institute for Plasma Science and Technology, CNR, Milan, Italy
| | - M Nocente
- Department of Physics, University of Milan-Bicocca, Milan, Italy
| | - E Perelli Cippo
- Institute for Plasma Science and Technology, CNR, Milan, Italy
| | - O Putignano
- Department of Physics, University of Milan-Bicocca, Milan, Italy
| | - M Rebai
- Institute for Plasma Science and Technology, CNR, Milan, Italy
| | - D Rigamonti
- Institute for Plasma Science and Technology, CNR, Milan, Italy
| | - E de la Luna
- Laboratorio Nacional de Fusión, CIEMAT, Madrid, Spain
| | - J Garcia
- CEA, IRFM, Saint-Paul-lez-Durance, France
| | - Y Kazakov
- Laboratory for Plasma Physics, ERM/KMS, Brussels, Belgium
| | - V Kiptily
- Culham Centre for Fusion Energy, United Kingdom Atomic Energy Authority, Abingdon, United Kingdom
| | - M Maslov
- Culham Centre for Fusion Energy, United Kingdom Atomic Energy Authority, Abingdon, United Kingdom
| | - M F F Nave
- Associacao EURATOM/IST, Universidade Tecnica de Lisboa, Lisbon, Portugal
| | - J Ongena
- Laboratory for Plasma Physics, ERM/KMS, Brussels, Belgium
| | - M Tardocchi
- Institute for Plasma Science and Technology, CNR, Milan, Italy
| |
Collapse
|
14
|
Nocente M, Kiptily V, Tardocchi M, Bonofiglo PJ, Craciunescu T, Molin AD, De La Luna E, Eriksson J, Garcia J, Ghani Z, Gorini G, Hägg L, Kazakov Y, Lerche E, Maggi CF, Mantica P, Marcer G, Maslov M, Putignano O, Rigamonti D, Salewski M, Sharapov S, Siren P, Stancar Z, Zohar A, Beaumont P, Crombe K, Ericsson G, Garcia-Munoz M, Keeling D, King D, Kirov K, Nave MFF, Ongena J, Patel A, Perez von Thun C. Fusion product measurements by nuclear diagnostics in the Joint European Torus deuterium-tritium 2 campaign (invited). Rev Sci Instrum 2022; 93:093520. [PMID: 36182523 DOI: 10.1063/5.0101767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/03/2022] [Accepted: 08/20/2022] [Indexed: 06/16/2023]
Abstract
A new deuterium-tritium experimental, DTE2, campaign has been conducted at the Joint European Torus (JET) between August 2021 and late December 2021. Motivated by significant enhancements in the past decade at JET, such as the ITER-like wall and enhanced auxiliary heating power, the campaign achieved a new fusion energy world record and performed a broad range of fundamental experiments to inform ITER physics scenarios and operations. New capabilities in the area of fusion product measurements by nuclear diagnostics were available as a result of a decade long enhancement program. These have been tested for the first time in DTE2 and a concise overview is provided here. Confined alpha particle measurements by gamma-ray spectroscopy were successfully demonstrated, albeit with limitations at neutron rates higher than some 1017 n/s. High resolution neutron spectroscopy measurements with the magnetic proton recoil instrument were complemented by novel data from a set of synthetic diamond detectors, which enabled studies of the supra-thermal contributions to the neutron emission. In the area of escaping fast ion diagnostics, a lost fast ion detector and a set of Faraday cups made it possible to determine information on the velocity space and poloidal distribution of the lost alpha particles for the first time. This extensive set of data provides unique information for fundamental physics studies and validation of the numerical models, which are key to inform the physics and scenarios of ITER.
Collapse
Affiliation(s)
- M Nocente
- Department of Physics, University of Milano-Bicocca, Milan 20126, Italy
| | - V Kiptily
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - M Tardocchi
- Institute for Plasma Science and Technology, National Research Council, Milan 20125, Italy
| | - P J Bonofiglo
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08540, USA
| | - T Craciunescu
- Institute of Atomic Physics, Magurele-Bucharest 077125, Romania
| | - A Dal Molin
- Institute for Plasma Science and Technology, National Research Council, Milan 20125, Italy
| | - E De La Luna
- Laboratorio Nacional de Fusión, CIEMAT, Madrid 28040, Spain
| | - J Eriksson
- Department of Physics and Astronomy, Uppsala University, Uppsala SE-75120, Sweden
| | - J Garcia
- CEA, IRFM, Saint Paul lez Durance 13115, France
| | - Z Ghani
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - G Gorini
- Department of Physics, University of Milano-Bicocca, Milan 20126, Italy
| | - L Hägg
- Department of Physics and Astronomy, Uppsala University, Uppsala SE-75120, Sweden
| | - Y Kazakov
- Laboratory for Plasma Physics, LPP ERM/KMS, Brussels 1000, Belgium
| | - E Lerche
- Laboratory for Plasma Physics, LPP ERM/KMS, Brussels 1000, Belgium
| | - C F Maggi
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - P Mantica
- Institute for Plasma Science and Technology, National Research Council, Milan 20125, Italy
| | - G Marcer
- Department of Physics, University of Milano-Bicocca, Milan 20126, Italy
| | - M Maslov
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - O Putignano
- Department of Physics, University of Milano-Bicocca, Milan 20126, Italy
| | - D Rigamonti
- Institute for Plasma Science and Technology, National Research Council, Milan 20125, Italy
| | - M Salewski
- Department of Physics, Technical University of Denmark, Kgs. Lyngby 2800, Denmark
| | - S Sharapov
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - P Siren
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - Z Stancar
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - A Zohar
- Jožef Stefan Institute, Ljubljana 1000, Slovenia
| | - P Beaumont
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - K Crombe
- Laboratory for Plasma Physics, LPP ERM/KMS, Brussels 1000, Belgium
| | - G Ericsson
- Department of Physics and Astronomy, Uppsala University, Uppsala SE-75120, Sweden
| | - M Garcia-Munoz
- Department of Atomic, Molecular and Nuclear Physics, University of Seville, Seville 41012, Spain
| | - D Keeling
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - D King
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - K Kirov
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - M F F Nave
- Instituto de Plasmas e Fusao Nuclear, IST, Universidade de Lisboa, Lisboa 1049-001, Portugal
| | - J Ongena
- Laboratory for Plasma Physics, LPP ERM/KMS, Brussels 1000, Belgium
| | - A Patel
- United Kingdom Atomic Energy Authority, Culham Centre for Fusion Energy, Culham Science Centre, Abingdon OX14 3DB, United Kingdom
| | - C Perez von Thun
- Institute of Plasma Physics and Laser Microfusion, Warsaw 01-497, Poland
| |
Collapse
|
15
|
Catalano A, Ade P, Aravena M, Barria E, Beelen A, Benoit A, Béthermin M, Bounmy J, Bourrion O, Bres G, De Breuck C, Calvo M, Désert FX, Durán C, Duvauchelle G, Eraud L, Fasano A, Fenouillet T, Garcia J, Garde G, Goupy J, Groppi C, Hoarau C, Hu W, Lagache G, Lambert JC, Leggeri JP, Levy-Bertrand F, Macías-Pérez J, Mani H, Marpaud J, Marton M, Mauskopf P, Monfardini A, Pisano G, Ponthieu N, Prieur L, Raffin G, Roni S, Roudier S, Tourres D, Tucker C, Vivargent L. CONCERTO at APEX: Installation and first phase of on-sky commissioning. EPJ Web Conf 2022. [DOI: 10.1051/epjconf/202225700010] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
CONCERTO (CarbON CII line in post-rEionisation and ReionisaTiOn) is a large field-of-view (FoV) spectro-imager that has been installed on the Cassegrain Cabin of Atacama Pathfinder EXperiment (APEX) telescope in April 2021. CONCERTO hosts 2 focal planes and a total number of 4000 Kinetic Inductance Detectors (KID), with an instantaneous FoV of 18.6 arcminutes in the range of 130-310 GHz. The spectral resolution can be easily tuned down to 1 GHz depending on the scientific target. The scientific program of CONCERTO has many objectives, with two main programs focused on mapping the fluctuations of the [CII] line intensity in the reionisation and postreionisation epoch (4.5<z<8.5), and on studying galaxy clusters via the thermal and kinetic Sunyaev-Zel’dovich (SZ) effect. CONCERTO will also measure the dust and molecular gas contents of local and intermediate-redshift galaxies, it will study the Galactic star-forming clouds and finally it will observe the CO intensity fluctuations arising from 0.3<z<2 galaxies.
The design of the instrument, installation at APEX and current status of the commissioning phase and science verification will be presented. Also we describe the deployment and first on-sky tests performed between April and June 2021.
Collapse
|
16
|
Schonrock N, Callis T, Hatchell K, Esplin E, Morales A, Garcia J, Vatta M, Nussbaum R. Precision Medicine Opportunities for Familial Arrhythmias and Cardiomyopathies Identified When Cost of Genetic Testing is Removed as a Barrier. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.04.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
17
|
Schonrock N, Morales A, Mitchell A, Garcia J, McKnight D, Callis T, Moretz C, Vatta M, Aradhya S. Genetic Testing Outcomes in a Cohort of 21,159 Children With Heart Disease. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.04.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
18
|
Chuong M, Herrera R, Mustafayev T, Gungor G, Ugurluer G, Atalar B, Kotecha R, Hall M, Rubens M, Mittauer K, Contreras J, Gutierrez A, Kalman N, Alvarez D, Romaguera T, McCulloch J, Garcia J, Kaiser A, Mehta M, Ozyar E. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART) With Median Biologically Effective Dose of 100 Gy10 for Oligometastases. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.1322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
19
|
Jaworski E, Fang F, Gharzai L, McFarlane M, Solanki A, Zaorsky N, Mahal B, Feng F, Ponsky L, Garcia J, Fredman E, Guo G, Berlin A, Roy S, Jackson W, Dess R, Schipper M, Spratt D. Utility of Long-Term Follow-Up to Determine Safety in Radiotherapy-Specific Trials for Localized Prostate Cancer: Meta-Analysis of 29 Randomized Trials. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
20
|
Conde E, Hernandez S, Caminoa A, Benito A, Martinez R, Alonso M, Jimenez B, Boni V, Remon J, Pijuan L, Clave S, Arriola E, Esteban I, De Castro J, Sansano I, Felip E, Abdulkader I, Garcia J, Rojo F, Domine M, Teixido C, Reguart N, Compañ D, Insa A, Mancheño N, Palanca S, Juan O, Baixeras N, Nadal E, Cebollero M, Calles A, Martin P, Salas C, Provencio M, Aranda I, Massuti B, Lopez-Vilaro L, Majem M, Enguita A, Paz-Ares L, Garrido P, Lopez-Rios F. MA14.02 RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Sternberg C, Bracarda S, de Bono J, Sweeney C, Chi K, Olmos D, Sandhu S, Massard C, Garcia J, Schenkel F, Chen G, Harris A, Hinton H, Matsubara N. 585P Safety analysis of the phase III IPATential150 trial of ipatasertib (ipat) plus abiraterone (abi) in patients with metastatic castration-resistant prostate cancer (mCRPC). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
22
|
Zeidan A, Garcia J, Fenaux P, Platzbecker U, Miyazaki Y, Xiao Z, Zhou Y, Naqvi K, Kye S, Manero GG. Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III. Leuk Res 2021. [DOI: 10.1016/j.leukres.2021.106681.52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
23
|
Lorenzo F, Youn. Obejero E, De. Camp. Echegoyen MJ, Garcia J, Felici M. P–704 Does the type of ovarian stimulation scheme and dose matter when calculating the amount of gonadotropins used to obtain an egg? Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
Is the controlled ovarian stimulation protocol important to determine the ovarian sensitivity index (number of oocytes retrieved / total gonadotropin dose)?
Summary answer
OSI in an interesting tool in estimating the ovarian sensitivity to exogenous gonadotropins and can be adjusted when different kinds of COS procotols are used.
What is known already
In our country, Argentina, as the fertility treatments are financed by different health care insurance companies, COS protocols may vary depending on the drugs provided. The objective of our study is to assess the oocyte retrieval number in patients undergoing COS, for IVF or fertility preservation (egg freezing), on the basis of the kind of protocol and the average gonadotropin dose.
Study design, size, duration
This is a retrospective and descriptive study in which 684 cycles, performed between November 2018 and March 2020, were evaluated. Patients underwent COS for IVF or fertility preservation purposes.
Participants/materials, setting, methods
COS protocols were analysed including different parameters such as: number of mature follicles (17mm or more) the trigger day, number of oocytes retrieved, number of M2 retrieved, follicle to oocyte index (FOI), and the kind of protocol.Each of these groups were divided into four groups depending on the protocol used. Group A: FSHr; Group B: FSHr/LHr; Group C: FSHr + HMG; Group D: Clomiphene citrate + HMG. Oocyte donors and incomplete medical records were excluded
Main results and the role of chance
The total number of cycles analysed was 684. There were 135(19.7%) cycles in the under 35 age group; 340(42%) in the 35 to 39 group; 209(38%) in the older than 40 group. They were subdivided in Group A: 54(6.67%) cycles; Group B 93(11.11%) cycles; Group C 465(71.72%); Group D 72(10.5%). A total number of 11351 oocytes were retrieved, with a mean average of 4.6 +- 2.5 SD per patient. Assessment of dose of gonadotropin per oocyte retrieved in each different group: GROUP A 360IU+–38 SD; GROUP B 390IU+–43 SD; GROUP C 375IU +–44 SD; GROUP D 479+–36 SD.
Limitations, reasons for caution
This is a retrospective study. Further prospective studies and a higher sample size are needed to confirm whether the OSI is a useful tool to adjust gonadotropins doses related to an specific COS protocol and improve the oocyte pick up.
Wider implications of the findings: The main conclusion obtained was that the average dose of gonadotropin needed to obtain one mature oocyte was 360 to 390 IU. The HMG and clomiphene citrate protocol needed the highest dose of gonadotropin (479 IU) but no significant stadistical differences were observed.
Trial registration number
NA
Collapse
Affiliation(s)
- F Lorenzo
- IFER Instituto de Ginecologia y Fertilidad, Reproductive Medicine, Buenos Aires, Argentina
| | - E Youn. Obejero
- IFER Instituto de Ginecologia y Fertilidad, Reproductive Medicine, Buenos Aires, Argentina
| | | | - J Garcia
- IFER Instituto de Ginecologia y Fertilidad, Reproductive Medicine, Buenos Aires, Argentina
| | - M Felici
- IFER Instituto de Ginecologia y Fertilidad, Reproductive Medicine, Buenos Aires, Argentina
| |
Collapse
|
24
|
Hernando-Requejo O, Lopez M, Chen X, Alonso R, Sanchez E, Montero A, Ciervide R, Alvarez B, Valero J, Garcia M, Zucca D, Garcia J, Garcia de Azilu P, Alonso L, De la Casa M, Prado A, Marti J, Fernandez Leton P, Nuñez M, Izquierdo M, Rossi K, Cañadillas C, Rubio C. PO-1240 Complete pathological response after high dose radiotherapy for locally advanced esophageal cancer. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07691-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
D'Atri D, Zerrillo L, Garcia J, Oieni J, Lupu-Haber Y, Schomann T, Chan A, Cruz LJ, Creemers LB, Machluf M. Nanoghosts: Mesenchymal Stem cells derived nanoparticles as a unique approach for cartilage regeneration. J Control Release 2021; 337:472-481. [PMID: 34015401 DOI: 10.1016/j.jconrel.2021.05.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Revised: 05/10/2021] [Accepted: 05/13/2021] [Indexed: 12/12/2022]
Abstract
Osteoarthritis (OA) is a chronic degenerative disease, which affects the joints and is characterized by inflammation, cartilage loss and bone changes. Nowadays, there are no treatments for OA, and current therapies are focused on relieving the symptoms. As a new therapy approach, micro and nanoparticles have been extensively explored and among all the studied particles, the use of cell-membrane-based particles is expanding. Another promising approach studied to treat OA, is the use of mesenchymal stem cells (MSCs) which play an important role modulating inflammation. We developed a novel kind of MSCs' cytoplasmic-membrane-based nanoparticles, termed nano-ghosts (NGs). Retaining MSCs' surface properties and lacking cells' internal machinery allow the NGs to have immunomodulatory capacity and to be immune-evasive while not susceptible to host-induced changes. In this study, we demonstrate NGs' ability to target cartilage tissues, in vitro and in vivo, while modulating the inflammatory process. In vivo studies demonstrated NGs ability to act as an immunomodulatory drug slowing down cartilage degeneration process. Our proof-of-concept experiments show that NGs system is a versatile nano-carrier system, capable of therapeutics loading, with targeting capabilities towards healthy and inflamed cartilage cells. Our results, along with previously published data, clearly reveal the NGs system as a promising nano-carrier platform and as a potential immunomodulatory drug for several inflammation-related diseases.
Collapse
Affiliation(s)
- D D'Atri
- Faculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Technion City, Haifa, Israel
| | - L Zerrillo
- Department of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, the Netherlands
| | - J Garcia
- Department of Orthopaedics, University Medical Center, 3584, CX, Utrecht, the Netherlands
| | - J Oieni
- Faculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Technion City, Haifa, Israel
| | - Y Lupu-Haber
- Faculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Technion City, Haifa, Israel
| | - T Schomann
- Department of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, the Netherlands
| | - A Chan
- Department of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, the Netherlands
| | - L J Cruz
- Department of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, the Netherlands
| | - L B Creemers
- Department of Orthopaedics, University Medical Center, 3584, CX, Utrecht, the Netherlands
| | - Marcelle Machluf
- Faculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Technion City, Haifa, Israel.
| |
Collapse
|
26
|
Garcia J, Tommasi C, Sessions D, Mah A, Bencomo T, Srivastava A, Amado A, Tsai K, Lopez-Pajares V, Lee C. 071 RET is a therapeutic target in cutaneous squamous cell carcinoma. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Mah A, Garcia J, Sessions D, Bencomo T, Amado A, Srivastava A, Lee C. 079 Somatic mutation of the OXA1L 5’UTR enables cutaneous squamous cell carcinoma. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
28
|
Schonrock N, Callis T, Hatchell K, Truty R, Esplin E, Morales A, Garcia J, Vatta M, Nussbaum R. Precision Medicine Opportunities for Familial Arrhythmias and Cardiomyopathies Identified When Cost of Genetic Testing is Removed as a Barrier. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
Geeraert P, Jamalidinan F, Bristow M, Lydell C, Howarth A, Fedak P, White J, Garcia J. Bicuspid aortic valve disease associates with abnormal wall shear stress, viscous energy loss, and pressure drop within the ascending thoracic aorta. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
We use 4D Flow MRI to (1) investigate the effects of bicuspid aortic valve (BAV) disease on downstream pressure drop (PD), wall shear stress (WSS), and viscous energy loss (EL) in the ascending aorta (AAo) and (2) explore the associations between AAo diameter and PD, WSS, and EL.
Hypothesis
BAV patients show increased PD, WSS, and EL in the AAo compared to age-matched controls
Methods
32 healthy controls (41±15 y, 10 female) and 53 BAV patients (44±16 y, 19 female) underwent cardiac MRI at 3T, inclusive of cine imaging and 4D flow. Cross sections were placed along segmented aortas at the: left ventricular outflow tract (LVOT), sinuses of Valsalva (SOV), mid-ascending aorta (MAA), and proximal to first aortic branch (AA1). Locations were analyzed for (i) net flow, (ii) aortic diameter (normalized to BSA), (iii) systolic PD (referenced to LVOT), (iv) systolic EL (measured within LVOT-AA1 volume and normalized by LVOT net flow; mW/mL), and (v) systolic WSS. Sub-vectors of WSS, axial (WSSax) and circumferential (WSScirc), were also analyzed.
Results
In comparison to controls, BAV patients showed greater PD (e.g. MAA: 9.5±8.0 vs. 2.8±2.4mmHg; p<0.01), EL (0.09±0.05 vs. 0.04±0.01 mW/mL; p≤0.01), and WSScirc (e.g. MAA: 0.3±0.1 vs. 0.2±0.06 Pa; p≤0.01) throughout the AAo (Table 1 and Fig. 1). BAV patients exhibited significantly lower WSS and WSSax only at the SOV. In univariate analyses, AAo diameter was inversely correlated with WSS (R=−0.32, p<0.01) and WSSax (R=−0.51, p≤0.01). In multivariate analyses, AAo diameter was associated with WSS (β=−0.36, p<0.01) and WSSax (β=−0.26, p<0.01).
Conclusions
BAV patients demonstrate significantly increased PD, EL, and WSScirc in the AAo, and an inverse association between AAo diameter and WSS measures.
Funding Acknowledgement
Type of funding source: Public Institution(s). Main funding source(s): Alberta Health Services
Collapse
Affiliation(s)
- P Geeraert
- University of Calgary Foothills Hospital, Calgary, Canada
| | - F Jamalidinan
- University of Calgary Foothills Hospital, Calgary, Canada
| | - M Bristow
- University of Calgary Foothills Hospital, Calgary, Canada
| | - C Lydell
- University of Calgary Foothills Hospital, Calgary, Canada
| | - A.G Howarth
- University of Calgary Foothills Hospital, Calgary, Canada
| | - P.W.M Fedak
- University of Calgary Foothills Hospital, Calgary, Canada
| | - J.A White
- University of Calgary Foothills Hospital, Calgary, Canada
| | - J Garcia
- University of Calgary Foothills Hospital, Calgary, Canada
| |
Collapse
|
30
|
Chuong M, Herrera R, Contreras J, Kotecha R, Kalman N, Garcia J, Romaguera T, Gutierrez A, Mittauer K, Alvarez D, Luciani G, Godley A, Hall M. Ablative Dose Prescribed to Oligometastases Near Gastrointestinal Luminal Structures is Well Tolerated Using Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART). Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Pooser RC, Savino N, Batson E, Beckey JL, Garcia J, Lawrie BJ. Truncated Nonlinear Interferometry for Quantum-Enhanced Atomic Force Microscopy. Phys Rev Lett 2020; 124:230504. [PMID: 32603167 DOI: 10.1103/physrevlett.124.230504] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2019] [Accepted: 05/15/2020] [Indexed: 06/11/2023]
Abstract
Nonlinear interferometers that replace beam splitters in Mach-Zehnder interferometers with nonlinear amplifiers for quantum-enhanced phase measurements have drawn increasing interest in recent years, but practical quantum sensors based on nonlinear interferometry remain an outstanding challenge. Here, we demonstrate the first practical application of nonlinear interferometry by measuring the displacement of an atomic force microscope microcantilever with quantum noise reduction of up to 3 dB below the standard quantum limit, corresponding to a quantum-enhanced measurement of beam displacement of 1.7 fm/sqrt[Hz]. Further, we minimize photon backaction noise while taking advantage of quantum noise reduction by transducing the cantilever displacement signal with a weak squeezed state while using dual homodyne detection with a higher power local oscillator. This approach may enable quantum-enhanced broadband, high-speed scanning probe microscopy.
Collapse
Affiliation(s)
- R C Pooser
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - N Savino
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
- Department of Physics and Engineering Physics, Tulane University, New Orleans, Louisiana 70118, USA
| | - E Batson
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
- Department of Physics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J L Beckey
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
- JILA, University of Colorado/NIST, Boulder, Colorado 80309, USA
| | - J Garcia
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - B J Lawrie
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| |
Collapse
|
32
|
Srinivasan N, Garcia J, Schilling RJ, Ahsan S, Babu G, Ang R, Dhinoja MJ, Hunter RJ, Chow AW, Lambiase PD. 126Dynamic high density functional substrate mapping improves outcomes in ventricular tachycardia ablation. Europace 2020. [DOI: 10.1093/europace/euaa162.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Activation and entrainment mapping of VT remains the gold standard for identifying critical sites for ablation of VT, however, this method is limited by poorly tolerated or non-sustained VT. Several substrate guided approaches have been developed, however, outcomes when comparing both methods are similar and overall success can be as low as 47%. A key element in facilitating VT is the presence of dynamic changes within the substrate which may not be evident during sinus rhythm substrate mapping, but may form a critical aspect of the tachycardia mechanism when conduction velocity slows dynamically and tissue refractory periods lengthen. These are rarely studied as part of clinical VT mapping.
Purpose
This study aimed to investigate dynamic substrate changes to local abnormal ventricular activity (LAVA) and late potentials (LP), in relation to critical sites for VT ablation using high resolution mapping of the ventricle with the HD Grid (Abbott, Inc, USA), during short coupled singe extra stimuli from the right ventricle (RV) (Barts Sense Protocol), designed to invoke conduction delay. We hypothesized that the dynamic functional late potential mapping would improve the identification of critical substrate and ablation of these regions would improve outcomes.
Methods
Thirty patients (age 67 +/- 9yrs, 27Male) underwent ablation. Mean ejection fraction was 25% (+/- 10%). Mapping was performed with the AdvisorTM HD Grid multipolar catheter. A bipolar voltage map was obtained during sinus rhythm (SR) and RV Sensed Protocol (SP) single extra pacing. SR and SP late potential (LP) and local abnormal ventricular activity (LAVA) maps were made and compared with critical sites for ablation, defined as sites of best entrainment or pace mapping. Ablation was then performed to critical sites and LP/LAVA identified by the SP.
Results
At a median follow up of 10 months 90% of patients were free from symptomatic ATP or ICD shocks. The median area of late potentials across the 30 patients during sinus rhythm was 6.4mm2 during sinus rhythm mapping and 19.3mm2 during sense protocol pacing (p = 0.001). The functional unmasking of LP and LAVA was seen in 26 patients and showed good correlation to critical regions of the VT circuit (sites of best entrainment or pace map). In 24 patients functionally unmasked late potentials were located within 10mm of critical regions within the mapped VT circuit, with a median distance of 8.5mm, compared to 7 patients during sinus rhythm mapping with a median distance of 22mm (p= <0.001). Figure 1 demonstrates and example of the SP, where increased functional LP are seen along the mapped VT isthmus.
Conclusion
Functional LP and LAVA can be unmasked by the sense protocol enabling better delineation of critical regions for VT ablation which may not be visible during sinus rhythm. This unique delineation of functional substrate changes combined with activation or pacemapping may improve outcomes.
Abstract Figure 1
Collapse
Affiliation(s)
- N Srinivasan
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - J Garcia
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - R J Schilling
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - S Ahsan
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - G Babu
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - R Ang
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - M J Dhinoja
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - R J Hunter
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - A W Chow
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| | - P D Lambiase
- Barts Heart Centre, London, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
33
|
Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Bakardjieva M, Raabe J, Neumann J, Stuchly J, Benes V, Garcia R, Garcia J, Diez P, Catala A, Neven B, Neth O, Olbrich P, Voll R, Alsina L, Allende L, Gonzales-Granado L, Thiel J, Venhoff N, Lorenzetti R, Unger S, Seidl M, Mielenz D, Schneider P, Ehl S, Rensing-Ehl A, Smulski C, Rizzi M. THU0053 CONTRIBUTION OF DEFECTIVE NON-APOPTOTIC FAS SIGNALING TO IMMUNE DYSREGULATION IN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS). Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:ALPS patients show impaired generation of humoral memory for T independent antigens whereas they generate memory for self-antigens due to impaired FAS-dependent removal of autoreactive germinal center B cells. It is known that FAS signaling via caspase activation results in cell apoptosis. However, FAS ligation may also initiate or modulate non-apoptotic signaling as shown for example by its ability to activate NF-κB. Recent data implicate a regulatory role of FAS in the modulation of mTOR signaling in ALPS double-negative T cells. Moreover, a recently described C194V FAS mutation disturbs its post-translational modification leading to impaired apoptosis induction while non-apoptotic signalling is still intact. Consequently, C194V FAS protects from the autoimmune phenotype in the murine ALPS system. This supports the view that FAS may prevent autoimmunity with other mechanisms than inducing apoptosis.Objectives:We hypothesize that FAS mutations impair this modulatory signaling, leading to hyper-activation of B cells. Therefore we aim to investigate non apoptotic FAS signaling in B cells derived from healthy individuals and ALPS patients.Methods:We studied resting and activated B cells in ALPS patients in presence or absence of FAS ligand by flow cytometry analysing relevant molecules to the CD40 signaling pathway. We used mass cytometry to perform functional phenotyping of B cells isolated from secondary lymphoid organs. Proteomic studies were performed to identify potential signaling circuits and RNA sequencing to study the consequences of FAS signaling on B cell fate.Results:In CD40L activated B cells, FAS signaling results in specific modulation of the mTOR signaling pathway. This modulation is absent in ALPS derived B cells. In line with these data germinal center B cells and plasmablast from secondary lymphoid organs of ALPS patients show hyperactive mTOR signaling pathway. Proteomic studies identify a circuit that links FAS to the phosphatase PTEN via DAXX and the deubiquitinase USP7.Conclusion:We describe a new role of FAS in the regulation of B cell activation. Defects in FAS signaling in ALPS contribute to dysregulation of the mTOR signaling pathway and disturbed B cell development.Disclosure of Interests:None declared
Collapse
|
34
|
Garcia J, Moore J, Payano L, Rogers A, Poke P, Casimir G, Jean-Louis G, Seixas A. 1102 Relationship Between Emotional Distress And Sleep Duration Among Hispanics Using The 2018 National Health Interview Survey Dataset. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.1097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Although Hispanics experience a high level of shorter sleep duration (< 7 hrs./24 period), a clear mechanism or cause is lacking. Previous research indicate that emotional distress may explain the burden of shorter sleep among blacks. Applying these findings to Hispanics, we investigated whether emotional distress explains the burden of short sleep duration (< 7 hrs.) among Hispanics and if this relationship varies by sex
Methods
We used data from the 2018 National Health Interview Survey (NHIS) dataset, a nationally representative sample, in which only Hispanic ethnicity participants (N=3,091) were analyzed. Average sleep duration was self-reported and measured in hours. Emotional distress was measured using Kessler 6, which measures how an individual felt over the past 30 days: nervous, hopeless, restless/fidgety, depressed, effortful and worthless. To assess the association between short sleep duration and emotional distress, we performed Pearson correlation, hierarchical regression analyses, and stratified this relationship by sex to determine if this relationship differed between males and females, adjusting for covariates.
Results
Of the total sample of 3,091 Hispanics, 1,762 were female, and 1,329 were male. Sleep duration and emotional distress were negatively correlated among females (r = -.27, p <.001) and males (r=-.18, p <.001). Among Hispanic females, sleep duration significantly predicted emotional distress, β = -.27, t = -11.60, p <.001, and explained a significant portion of variance in emotional distress, R2 = .07, F= 134.63, p <.001. While, among Hispanic males, sleep significantly predicted emotional distress (β = -.18, t =-6.5, p <.001) and explained a significant portion of the variance in emotional distress (R2 = .03, F= 42.37, p <.001).
Conclusion
Our findings indicate that a negative sleep-ED relationship, suggesting that shorter sleep was predictive of higher levels of emotional distress among Hispanics and that this relationship is greater among Hispanic females, compared males.
Support
K01HL135452, R01MD007716, R01HL142066, and K07AG052685
Collapse
Affiliation(s)
- J Garcia
- NYU Grossman School of Medicine, New York, NY
| | - J Moore
- NYU Grossman School of Medicine, New York, NY
| | - L Payano
- NYU Grossman School of Medicine, New York, NY
| | - A Rogers
- St. John’s University, Queens, NY
| | - P Poke
- NYU Grossman School of Medicine, New York, NY
| | - G Casimir
- SUNY Downstate Medical Center, Brooklyn, NY
| | | | - A Seixas
- NYU Grossman School of Medicine, New York, NY
| |
Collapse
|
35
|
Aird C, Seixas A, Moore J, Nunes J, Gyamfi L, Garcia J, Blanc J, Williams N, Zizi F, Jean-Louis G. 1189 Recruiting, Training, And Implementing Sleep Health Educators In Community-based Research To Improve Sleep Health. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.1183] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Introduction
Adherence to OSA assessment and treatment is low among racial/ethnic minorities, particularly among blacks. Navigating patients along the continuum of care from assessment to treatment adherence requires motivation, social support, and self-efficacy. Previous studies indicate that community health educators can provide motivation, social support, and skills to patients to better navigate the complex OSA care continuum. However, recruiting, training, and implementing sleep health educators in clinical or research settings is complex. For the current study, we describe how we recruit, train, and implement sleep health educators in research and clinical settings and assess what makes a sleep health educator successful.
Methods
We recruited and trained twenty-five self-identified black sleep health educators for a randomized clinical trial (R01MD007716) focused on increasing OSA assessment and treatment adherence among blacks. During recruitment, we assessed key personality attributes that translate to being an effective sleep health educator, via behavioral and personality surveys, focused groups, and process forms filled out by educators. Sleep health educators underwent an 8-week training program on sleep health and motivational interviewing. In order to be certified, sleep health educators had to pass a written and scenario-based assessment. During the implementation phase of the trial, we assessed how many interviews each health educator conducted and whether individual characteristics were related to how many interviews.
Results
Of the trained educators, 80% were female, ranging from 25 to 58 years old. They all completed at least high school. All educators rated the program highly and were very satisfied with dispensing tailored sleep health education. Educators who displayed the highest knowledge about sleep health, provided frequent emotional and strategic support, committed to helping their assigned participants, and who rated their rapport highly with their assigned participants were most effective in getting their participant to adhere to OSA assessment and treatment.
Conclusion
Sleep health educators can be vital to increasing OSA assessment and treatment adherence among blacks. In order to ensure success, sleep health educators must undergo a thorough recruitment, training, and implementation and dissemination process.
Support
K01HL135452, R01MD007716, R01HL142066, K01HL135452,and K07AG052685
Collapse
Affiliation(s)
- C Aird
- NYU Grossman School of Medicine, New York, NY
| | - A Seixas
- NYU Grossman School of Medicine, New York, NY
| | - J Moore
- NYU Grossman School of Medicine, New York, NY
| | - J Nunes
- City College/ CUNY, New York, NY
| | - L Gyamfi
- NYU Grossman School of Medicine, New York, NY
| | - J Garcia
- NYU Grossman School of Medicine, New York, NY
| | - J Blanc
- NYU Grossman School of Medicine, New York, NY
| | - N Williams
- NYU Grossman School of Medicine, New York, NY
| | - F Zizi
- NYU Grossman School of Medicine, New York, NY
| | | |
Collapse
|
36
|
Flynn-Evans EE, Hilditch CJ, Chachad R, Bansal K, Wong LR, Santamaria A, Bathurst NG, Feick NH, Garcia J. 0078 Influence of Light on Brain Activity Upon Waking From Slow Wave Sleep. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.076] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Waking from sleep is associated with reduced alertness due to sleep inertia. Light acutely improves alertness during sleep deprivation. In this study we assessed the influence of light on brain activity and connectivity after waking from slow wave sleep (SWS).
Methods
Twelve participants kept an actigraphy-confirmed stable sleep schedule with 8.5 hours for five nights and five hours for one night prior to an overnight laboratory visit. Participants completed two three-minute Karolinska Drowsiness Tests (KDT) before going to bed at their habitual bedtime. They were monitored continuously using high-density EEG (32-channel; Brain Products GmbH). Participants were woken twice and exposed to red light (0.01 melanopic-lux; control) or blue-enriched light (63.62 melanopic-lux) for one hour, in a randomized order, following at least five minutes of SWS. EEG artifact were removed algorithmically and the spectral composition of each electrode (i.e., fast fourier transform, FFT) and effective connectivity (i.e., partial directed coherence, PDC) between each electrode were estimated. A graphical analysis was conducted to extract features relevant to the facilitation of efficient communication between electrodes. All data were averaged within frequency bins of interest that correspond to delta (1-3Hz), theta (4-7Hz), alpha (8-12Hz), and beta (13-25Hz) bands and expressed relative to the pre-sleep baseline.
Results
Compared to the pre-sleep baseline, participants exposed to blue-enriched light experienced reduced theta and alpha activity; however, these results were not significantly different from the control. In contrast, the communication of frontal electrodes significantly increased across all frequency bands compared to the control, and this effect was most prominent in the alpha (t(11)=3.80, p=.005) and beta bands (t(11)=3.92, p=.004).
Conclusion
Exposure to blue-enriched light immediately after waking from SWS may accelerate the process of waking and help to improve alertness by facilitating communication between brain regions. Future analyses will explore the temporal persistence and granularity of the communicative properties associated with this response.
Support
Naval Postgraduate School Grant. NASA Airspace Operations and Safety Program, System-Wide Safety Project.
Collapse
Affiliation(s)
- E E Flynn-Evans
- Fatigue Countermeasures Lab, NASA Ames Research Center, Moffett Field, CA
| | - C J Hilditch
- Fatigue Countermeasures Lab, SJSU Research Foundation, Moffett Field, CA
| | - R Chachad
- Fatigue Countermeasures Lab, SJSU Research Foundation, Moffett Field, CA
| | | | - L R Wong
- Fatigue Countermeasures Lab, SJSU Research Foundation, Moffett Field, CA
| | - A Santamaria
- University of South Australia, Adelaide, AUSTRALIA
| | - N G Bathurst
- Fatigue Countermeasures Lab, SJSU Research Foundation, Moffett Field, CA
| | - N H Feick
- Fatigue Countermeasures Lab, SJSU Research Foundation, Moffett Field, CA
| | | |
Collapse
|
37
|
Coll R, Vidal J, Kumru H, Benito J, Valles M, Codinach M, Blanco M, Vives J, Querol S, Salvador F, Nogués N, Rodriguez L, Garcia J. Is HLA matching relevant for treating Spinal Cord Injury with intrathecal administration of expanded Wharton's Jelly Mesenchymal Stromal Cells? Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Kvale E, Garcia J, Kalff S, Solano M. Short-Term Postoperative Complications and Outcome after Surgical Stabilization of Medial and Lateral Humeral Condylar Fractures in Dogs Using a Locking Implant System. Vet Comp Orthop Traumatol 2020. [DOI: 10.1055/s-0040-1712900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- E Kvale
- Fitzpatrick Referrals, Godalming, United Kingdom
| | - J Garcia
- School of Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom
| | - S Kalff
- Pacific and Santa Cruz Veterinary Specialists, Santa Cruz, California, United States
| | - M Solano
- Fitzpatrick Referrals, Godalming, United Kingdom
| |
Collapse
|
39
|
Sanchez P, Cantu E, Hartwig M, D'Ovidio F, Machuca T, Whitson B, Daneshmand M, Bermudez C, Mulligan M, D'Cunha J, Weyant M, Lynch W, Garcia J, Caldeira C, Nemeh H, Song T, Kreisel D, Jessen M, Camp P, Ramzy D, Griffith B, Davis D. The NOVEL Study. A Multi-Center Clinical Trial Studying the Safety of Ex Vivo Lung Perfusion. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.977] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
40
|
Sawhney V, Mc Lellan A, Chatha S, Perera D, Aderonke A, Juno S, Whittaker-Axon S, Daw H, Garcia J, Lambiase PD, Cullen S, Bhan A, Von Klemperer K, Walker F, Pandya B, Lowe MD, Ezzat V. Outcome of ACHD patients with non-inducible versus inducible IART undergoing cavo-tricuspid isthmus ablation: the role of empiric ablation. J Interv Card Electrophysiol 2020; 60:49-56. [PMID: 31997041 DOI: 10.1007/s10840-019-00692-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2019] [Accepted: 12/19/2019] [Indexed: 10/25/2022]
Abstract
PURPOSE Catheter ablation for supraventricular tachycardia (SVT) in adults with congenital heart disease (ACHD) is an important therapeutic option. Cavo-tricuspid isthmus (CTI)-dependent intraatrial re-entrant tachycardia (IART) is common. However, induction of sustained tachycardia at the time of ablation is not always possible. We hypothesised that performing an empiric CTI line in case of non-inducibility leads to good outcomes. Long-term outcomes of empiric versus entrained CTI ablation in ACHD patients were examined. METHODS Retrospective, single-centre, case-control study over 7 years. Arrhythmia-free survival after empiric versus entrained CTI ablation was compared. RESULTS Eighty-seven CTI ablations were performed in 85 ACHD patients between 2010 and 2017. The mean age of the cohort was 43 years and 48% were male. Underlying aetiology included ASD (31%), VSD (11.4%), AVSD (9.1%), AVR (4.8%), Fallot's (18.4%), Ebstein's (2.3%), Fontan's palliation (9.2%) and atrial switch (13.8%). CTI-dependent IART was entrained in 59 patients whereas it was non-inducible in 28. The latter had an empiric CTI ablation. Forty-three percent of procedures were performed under general anaesthesia. There were no reported procedural complications. There was no significant difference in the mean procedure or fluoroscopy times between the groups (empiric vs entrained CTI; 169.1 vs 183.3 and 28.1 vs 19.9 min). Arrhythmia-free survival was 64.3% versus 72.8% (p value 0.44) in the empiric and entrained groups at 21 months follow-up. CONCLUSIONS Long-term outcomes after empiric and entrained CTI ablation for IART in ACHD patients are comparable. This is a safe and effective therapeutic option. In the case of non-inducibility of IART, an empiric CTI line should be considered in this cohort.
Collapse
Affiliation(s)
- V Sawhney
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK. .,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
| | - A Mc Lellan
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Chatha
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - D Perera
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - A Aderonke
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Juno
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Whittaker-Axon
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - H Daw
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK.,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - J Garcia
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - P D Lambiase
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Cullen
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - A Bhan
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - K Von Klemperer
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - F Walker
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - B Pandya
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - M D Lowe
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK.,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - V Ezzat
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK.,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| |
Collapse
|
41
|
Gilfoyle M, Garcia J, Chaurasia A, Oremus M. Perceived susceptibility to developing cancer and mammography screening behaviour: a cross-sectional analysis of Alberta's Tomorrow Project. Public Health 2019; 177:135-142. [DOI: 10.1016/j.puhe.2019.08.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Revised: 06/28/2019] [Accepted: 08/08/2019] [Indexed: 10/25/2022]
|
42
|
Trombella BE, Caputi A, Musso D, Ribeiro A, Ryan T, Andrade G, Burns G, Eder R, Gallego RG, Garcia J, Goriel A, Kupina S, Mabud A, Masschelin; J, Roberts D, Tusseau D, Wittkowski R. Determination of Fluoride in Wine by Fluoride Selective Ion Electrode, Standard Addition Method: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/86.6.1203] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
The accuracy, precision, and reproducibility of a rapid method for determination of fluoride in wine, using a fluoride selective ion electrode, were established by a collaborative study involving 12 laboratories, 5 in Europe and 7 in the United States. The laboratories assayed 6 Youden pairs of fluo-ride-fortified, red and white wine samples with fluoride concentrations ranging from 0.2 to 3.0 mg/L. The relative standard deviations of repeatability ranged from 1.94 to 4.88%; relative standard deviations of reproducibility ranged from 4.15 to 18.40%. HORRAT values ranged from 0.30 to 0.97. The average recovery was 99.97%. Based on the statistical results of this collaborative study, the Study Director recommends that this method be adopted First Action.
Collapse
Affiliation(s)
- Bruno E Trombella
- E&J Gallo Winery, Analytical and Chemical Sciences Departments, PO Box 1130, Modesto, CA 95353
| | - Arthur Caputi
- E&J Gallo Winery, Analytical and Chemical Sciences Departments, PO Box 1130, Modesto, CA 95353
| | - Daniel Musso
- E&J Gallo Winery, Analytical and Chemical Sciences Departments, PO Box 1130, Modesto, CA 95353
| | - Anthony Ribeiro
- E&J Gallo Winery, Analytical and Chemical Sciences Departments, PO Box 1130, Modesto, CA 95353
| | - Timothy Ryan
- E&J Gallo Winery, Analytical and Chemical Sciences Departments, PO Box 1130, Modesto, CA 95353
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Garcia J, Monjaret F, Geiguer F, Aurel JP, Puisieux A, Morel A, Bardel C, Vilchez G, Brigitte M, Couraud S, Vigneron A, Tourniaire G, Payen-Gay L. Whole transcriptomics analyses of mimicking circulating tumor cells (CTCs) by single-cell RNA sequencing (scRNAseq). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz238.044] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
44
|
Busto SA, Varela V, Fernandez N, Firvida X, Santome L, Afonso J, Azpiarte C, De Dios Alvarez N, Garcia J, Campos B, Areses M, Pereiro D, Lazaro M. EP1.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
45
|
Garrido P, Campelo RG, Majem M, Carcereny E, Isla D, Larriba JG, Coves J, De Castro Carpeno J, Domine M, Lianes P, Juan O, Terrassa J, Provencio M, Blasco A, Garcia J, De Las Peñas RG, Artal A, Remon J, Catot S, Felip E, Viñolas N. MA22.05 Assessment of Gender Differences in the Psychosocial and Economic Impact on Patients with Stage IV Non-Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
46
|
Vallar M, Karpushov A, Agostini M, Bolzonella T, Coda S, Duval B, Fasoli A, Galperti C, Garcia J, Geiger B, Goodman T, Jacquier R, Labit B, Maurizio R, Pimazzoni A, Piron C, Serianni G, Testa D, Valisa M, Veltri P, Vianello N. Status, scientific results and technical improvements of the NBH on TCV tokamak. Fusion Engineering and Design 2019. [DOI: 10.1016/j.fusengdes.2019.01.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Rubio C, Chen X, Lopez M, Hernando O, Sanchez E, Montero A, Aranda MG, Ciervide R, Valero J, Alonso R, Vicente E, Quijano Y, Cubillo A, Gallego RA, Prados S, Plaza C, Pérez J, Garcia J, Zucca D, Leton PF. A Prospective Observational Study of the Impact of Stereotactic Body Radiotherapy (SBRT) As a Neoadjuvant Strategy of Chemoradiation in Pancreatic Cancer. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
48
|
Frégeau G, Sarduy R, Ménard L, Elimam H, Leitão da Graça S, Garcia J, Lubell W, Ong H, Marleau S. Atheroregressive Potential Of Azapeptides Analogues Of Ghrp-6 As Selective Cd36 Ligands In Apolipoprotein E-Deficient Mice. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Guiñon L, Soler A, Marin J, Molina A, Lopez R, Garcia J, Jimenez W, Mira A, Alvarez L. Analytical performance specifications based on the state-of-the-art for the magnitudes included in the Spanish newborn screening program. Clin Chim Acta 2019. [DOI: 10.1016/j.cca.2019.03.1110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Rodriguez M, Fernandez-Miranda I, Mondejar R, Capote J, Rodriguez-Pinilla S, Cereceda L, Alonso R, Cordoba R, Provencio M, Martin-Acosta P, Sanchez A, Pedrosa L, Gómez S, Piris-Villaespesa M, Garcia-Cosio M, Quero C, Llanos M, Barcena C, Fraga M, Camacho F, Castro Y, Garcia J, Mollejo M, Climent F, Mayordomo E, Bacalari E, Olmedilla G, Sánchez-Beato M, Piris M. DIFFUSE LARGE B-CELL LYMPHOMA SURVIVAL PROGNOSTICATION, A COMPARATIVE ANALYSIS OF CELL OF ORIGIN VS. MYC/BCL2 EXPRESSION. Hematol Oncol 2019. [DOI: 10.1002/hon.15_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- M. Rodriguez
- Pathology; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Investigación Fundación Jiménez Díaz; Madrid Spain
| | - I. Fernandez-Miranda
- Medical Oncology; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana; Madrid Spain
| | - R. Mondejar
- Haematology; Hospital Universitario Virgen del Rocío, Sevilla; Spain
| | - J. Capote
- Medical Oncology; Instituto de Investigación Fundación Jiménez Díaz; Madrid Spain
| | - S. Rodriguez-Pinilla
- Pathology; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Investigación Fundación Jiménez Díaz; Madrid Spain
| | - L. Cereceda
- Pathology; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Investigación Fundación Jiménez Díaz; Madrid Spain
| | - R. Alonso
- Pathology; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Investigación Fundación Jiménez Díaz; Madrid Spain
| | - R. Cordoba
- Haematology; Instituto de Investigación Fundación Jiménez Díaz; Madrid Spain
| | - M. Provencio
- Medical Oncology; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana; Madrid Spain
| | - P. Martin-Acosta
- Pathology; Instituto Investigación Sanitaria Puerta de Hierro-Segovia de Arana; Madrid Spain
| | - A. Sanchez
- Medical Oncology; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana; Madrid Spain
| | - L. Pedrosa
- Medical Oncology; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana; Madrid Spain
| | - S. Gómez
- Medical Oncology; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana; Madrid Spain
| | | | - M. Garcia-Cosio
- Haematology; Instituto de Investigación Hospital Ramón y Cajal; Madrid Spain
| | - C. Quero
- Medical Oncology; Hospital Universitario Virgen de la Victoria; Málaga Spain
| | - M. Llanos
- Medical Oncology; Hospital Universitario de Canarias; Santa Cruz de Tenerife Spain
| | - C. Barcena
- Pathology; Instituto de Investigación Hospital 12 de Octubre; Madrid Spain
| | - M. Fraga
- Pathology; Hospital Clínico Universitario de Santiago-CHUS, Santiago de Compostela; A Coruña Spain
| | - F. Camacho
- Pathology; Hospital Universitario de Getafe; Madrid Spain
| | - Y. Castro
- Pathology; Hospital Universitario Príncipe de Asturias; Madrid Spain
| | - J. Garcia
- Pathology; Hospital MD Anderson Cancer Center; Madrid Spain
| | - M. Mollejo
- Pathology; Hospital Virgen de la Salud; Toledo Spain
| | - F. Climent
- Pathology; Hospital Universitario de Bellvitge; Barcelona Spain
| | - E. Mayordomo
- Pathology; Hospital Universitario y Politécnico de La Fe; Valencia Spain
| | - E. Bacalari
- Pathology; Hospital Universitario La Paz; Madrid Spain
| | - G. Olmedilla
- Pathology; Hospital Universitario La Paz; Madrid Spain
| | - M. Sánchez-Beato
- Medical Oncology; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana; Madrid Spain
| | - M. Piris
- Pathology; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Investigación Fundación Jiménez Díaz; Madrid Spain
| |
Collapse
|